Literature DB >> 26298625

Comparing the Use of Centers for Disease Control and Prevention and World Health Organization Growth Charts in Children with Cystic Fibrosis through 2 Years of Age.

Zhumin Zhang1, Suzanne M Shoff2, HuiChuan J Lai3.   

Abstract

OBJECTIVE: To examine differences between use of World Health Organization (WHO) and Centers for Disease Control and Prevention (CDC) growth reference in children with cystic fibrosis (CF) up to 2 years of age. STUDY
DESIGN: Growth from 1-24 months in 2587 children, born 2003-2006 and recorded in the US CF Foundation Registry, was evaluated using WHO and CDC references.
RESULTS: In both boys and girls with CF aged 1-24 months, use of WHO charts resulted in ∼8 percentile lower length-for-age and ∼13% higher short stature rate (length-for-age <5th percentile). WHO weight-for-age was ∼9 percentile lower prior to age 6 months, crossed at 6-7 months, and remained ∼14 percentile higher at 8-24 months. WHO weight-for-length (WFL) percentile (WFLp) was similar before 12 months but ∼10 percentile higher at 12-24 months compared with CDC. When using WHO charts, 9% of children had underweight (WFLp <50th) classified differently and this rate varied with age: 4% in the first year, 7% at 12, 13% at 15, and 16% at 18 months, respectively. Weight status assessed by WHO body mass index (BMI) charts was different from WHO WFL charts. At 24 months when switching back to CDC, 26% of children with normal WFLp on WHO charts appeared underweight on CDC charts. A 70th percentile of WHO BMI percentile was equivalent to the 50th percentile CDC BMI percentile.
CONCLUSIONS: Growth status in children with CF differed when using WHO and CDC references, particularly during the second year of life. These differences need to be considered for all uses of growth assessment in CF.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26298625      PMCID: PMC4661080          DOI: 10.1016/j.jpeds.2015.07.036

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  16 in total

Review 1.  Consensus report on nutrition for pediatric patients with cystic fibrosis.

Authors:  Drucy Borowitz; Robert D Baker; Virginia Stallings
Journal:  J Pediatr Gastroenterol Nutr       Date:  2002-09       Impact factor: 2.839

2.  Weight-for-stature compared with body mass index-for-age growth charts for the United States from the Centers for Disease Control and Prevention.

Authors:  Katherine M Flegal; Rong Wei; Cynthia Ogden
Journal:  Am J Clin Nutr       Date:  2002-04       Impact factor: 7.045

3.  Relative underweight in cystic fibrosis and its prognostic value.

Authors:  R Kraemer; A Rüdeberg; B Hadorn; E Rossi
Journal:  Acta Paediatr Scand       Date:  1978-01

4.  Comparison of the WHO child growth standards and the CDC 2000 growth charts.

Authors:  Mercedes de Onis; Cutberto Garza; Adelheid W Onyango; Elaine Borghi
Journal:  J Nutr       Date:  2007-01       Impact factor: 4.798

5.  Growth failure in cystic fibrosis.

Authors:  S A McNaughton; D A Stormont; R W Shepherd; P W Francis; B Dean
Journal:  J Paediatr Child Health       Date:  1999-02       Impact factor: 1.954

6.  Failure to thrive: the earliest feature of cystic fibrosis in infants diagnosed by neonatal screening.

Authors:  L Giglio; M Candusso; C D'Orazio; G Mastella; D Faraguna
Journal:  Acta Paediatr       Date:  1997-11       Impact factor: 2.299

7.  Growth status in children with cystic fibrosis based on the National Cystic Fibrosis Patient Registry data: evaluation of various criteria used to identify malnutrition.

Authors:  H C Lai; M R Kosorok; S A Sondel; S T Chen; S C FitzSimmons; C G Green; G Shen; S Walker; P M Farrell
Journal:  J Pediatr       Date:  1998-03       Impact factor: 4.406

8.  2000 CDC Growth Charts for the United States: methods and development.

Authors:  Robert J Kuczmarski; Cynthia L Ogden; Shumei S Guo; Laurence M Grummer-Strawn; Katherine M Flegal; Zuguo Mei; Rong Wei; Lester R Curtin; Alex F Roche; Clifford L Johnson
Journal:  Vital Health Stat 11       Date:  2002-05

9.  Comparison of WHO and CDC growth charts in predicting pulmonary outcomes in cystic fibrosis.

Authors:  Evans Machogu; Yumei Cao; Tami Miller; Pippa Simpson; Hara Levy; Diana Quintero; Praveen S Goday
Journal:  J Pediatr Gastroenterol Nutr       Date:  2015-03       Impact factor: 2.839

10.  The changing epidemiology of cystic fibrosis.

Authors:  S C FitzSimmons
Journal:  J Pediatr       Date:  1993-01       Impact factor: 4.406

View more
  5 in total

1.  Growth Deficiency in Cystic Fibrosis Is Observable at Birth and Predictive of Early Pulmonary Function.

Authors:  Rebecca Darrah; Rebecca Nelson; Elizabeth G Damato; Michael Decker; Anne Matthews; Craig A Hodges
Journal:  Biol Res Nurs       Date:  2016-04-13       Impact factor: 2.522

2.  Early life growth patterns persist for 12 years and impact pulmonary outcomes in cystic fibrosis.

Authors:  Don B Sanders; Zhumin Zhang; Philip M Farrell; HuiChuan J Lai
Journal:  J Cyst Fibros       Date:  2018-02-01       Impact factor: 5.482

3.  Academy of Nutrition and Dietetics: 2020 Cystic Fibrosis Evidence Analysis Center Evidence-Based Nutrition Practice Guideline.

Authors:  Catherine M McDonald; Jessica A Alvarez; Julianna Bailey; Ellen K Bowser; Kristen Farnham; Mark Mangus; Laura Padula; Kathleen Porco; Mary Rozga
Journal:  J Acad Nutr Diet       Date:  2020-06-19       Impact factor: 5.234

4.  Growth assessment and risk factors of malnutrition in children with cystic fibrosis.

Authors:  Mahmood D Al-Mendalawi
Journal:  Saudi Med J       Date:  2016-06       Impact factor: 1.484

5.  Reduced bone length, growth plate thickness, bone content, and IGF-I as a model for poor growth in the CFTR-deficient rat.

Authors:  Michael S Stalvey; Viktoria Havasi; Katherine L Tuggle; Dezhi Wang; Susan Birket; Steve M Rowe; Eric J Sorscher
Journal:  PLoS One       Date:  2017-11-30       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.